Detection of FUS-ERG chimeric transcript in two cases of acute myeloid leukemia with t(16;21)(p11.2;q22) with unusual characteristics

Cancer Genetics and Cytogenetics

Volumn 194, Issue 2, 2009, Pages 111-118

  Kim, Juwon ^a   Park, Tae Sung ^b   Song, Jaewoo ^a   Lee, Kyung A ^a   Hong, Duk Jin ^a   Min, Yoo Hong ^a   Cheong, June Won ^a   Choi, Jong Rak ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; CHROMOSOME PROTEIN; CYTARABINE; FUS PROTEIN; IDARUBICIN; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BACKACHE; BASOPHILIA; BONE MARROW BIOPSY; BRAIN DISEASE; CASE REPORT; CENTRAL NERVOUS SYSTEM METASTASIS; CHIMERA; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 21; CONTROLLED STUDY; DRUG MEGADOSE; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOCHEZIA; HOSPITAL READMISSION; HUMAN; LEG PAIN; LEUKEMIA REMISSION; MALE; MELENA; MINIMAL RESIDUAL DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RECIPROCAL CHROMOSOME TRANSLOCATION; VEIN OCCLUSION;

ADULT; AGED; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 21; CYTOGENETIC ANALYSIS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; RNA-BINDING PROTEIN FUS; TRANSLOCATION, GENETIC;

ALIAS;

EID: 70349209103     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.06.010     Document Type: Article

References (47)

1. Mecucci C., Bosly A., Michaux J.L., Broeckaert-Van Orshoven A., and Van den Berghe H. Acute nonlymphoblastic leukemia with bone marrow eosinophilia and structural anomaly of chromosome 16. Cancer Genet Cytogenet 17 (1985) 359-363
2. Ferro M.R., Cabello P., Garcia-Sagredo J.M., Resino M., San Roman C., and Larana J.G. t(16;21) in a Ph positive CML. Cancer Genet Cytogenet 60 (1992) 210-211
3. Yao E., Sadamori N., Nakamura H., Sasagawa I., Itoyama T., Ichimaru M., Tagawa M., Nakamura I., and Kamei T. Translocation t(16;21) in acute nonlymphocytic leukemia with abnormal eosinophils. Cancer Genet Cytogenet 36 (1988) 221-223
4. Kanazawa T., Ogawa C., Taketani T., Taki T., Hayashi Y., and Morikawa A. TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease. Leuk Lymphoma 46 (2005) 1833-1835
5. Berkowicz M., Rosner E., Resnitzky P., Mamon Z., Ben-Bassat I., and Ramot B. Acute nonlymphocytic leukemia with t(16;21). Cancer Genet Cytogenet 47 (1990) 139-140
6. Dastugue N., Lafage-Pochitaloff M., Pages M.P., Radford I., Bastard C., Talmant P., Mozziconacci M.J., Leonard C., Bilhou-Nabera C., Cabrol C., Capodano A.M., Cornillet-Lefebvre P., Lessard M., Mugneret F., Perot C., Taviaux S., Fenneteaux O., Duchayne E., and Berger R. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH). Blood 100 (2002) 618-626
7. Nobbs M.C., Chan-Lam D., Howell R.T., Kitchen C., and Copplestone J.A. Acute non-lymphocytic leukemia with t(16;21). Cancer Genet Cytogenet 70 (1993) 144-145
8. Okada K., Takeichi M., Uchida H., Shirota T., Sakai N., and Ito H. Translocation (16;21)(p11;q22) in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 75 (1994) 60-63
9. Shikami M., Miwa H., Nishii K., Takahashi T., Shiku H., Tsutani H., Oka K., Hamaguchi H., Kyo T., Tanaka K., Kamada N., and Kita K. Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin-2 receptor α chain. Br J Haematol 105 (1999) 711-719
10. Marosi C., Bettelheim P., Geissler K., Lechner K., Koller U., Haas O.A., Chott A., and Hagemeijer A. Translocation (16;21)(p11;q22) in acute monoblastic leukemia with erythrophagocytosis. Cancer Genet Cytogenet 54 (1991) 61-66
11. Shimizu K., Ichikawa H., Tojo A., Kaneko Y., Maseki N., Hayashi Y., Ohira M., Asano S., and Ohki M. An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc Natl Acad Sci U S A 90 (1993) 10280-10284
12. Zucman J., Melot T., Desmaze C., Ghysdael J., Plougastel B., Peter M., Zucker J.M., Triche T.J., Sheer D., Turc-Carel C., Amros P., Combaret V., Lenoir G., Aurias A., Thomas G., and Delattre O. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12 (1993) 4481-4487
13. Aman P., Ron D., Mandahl N., Fioretos T., Heim S., Arheden K., Willen H., Rydholm A., and Mitelman F. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 5 (1992) 278-285
14. Ichikawa H., Shimizu K., Hayashi Y., and Ohki M. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54 (1994) 2865-2868
15. Panagopoulos I., Aman P., Fioretos T., Hoglund M., Johansson B., Mandahl N., Heim S., Behrendtz M., and Mitelman F. Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11 (1994) 256-262
16. Berger R., and Bernard O.A. Jumping translocations. Genes Chromosomes Cancer 46 (2007) 717-723
17. Gray B.A., Bent-Williams A., Wadsworth J., Maiese R.L., Bhatia A., and Zori R.T. Fluorescence in situ hybridization assessment of the telomeric regions of jumping translocations in a case of aggressive B-cell non-Hodgkin lymphoma. Cancer Genet Cytogenet 98 (1997) 20-27
18. Devriendt K., Petit P., Matthijs G., Vermeesch J.R., Holvoet M., De Muelenaere A., Marynen P., Cassiman J.J., and Fryns J.P. Trisomy 15 rescue with jumping translocation of distal 15q in Prader-Willi syndrome. J Med Genet 34 (1997) 395-399
19. Fan Y.S., Rizkalla K., William B.F., and Engel C.J. Jumping translocations of 11q in acute myeloid leukemia and 1q in follicular lymphoma. Cancer Genet Cytogenet 118 (2000) 35-41
20. Jarvis A., Sharma P., Watson N., and Smith A. Two children with acute lymphoblastic leukemia and "jumping" translocations: both involve 1q23 as the donor breakpoint. Cancer Genet Cytogenet 114 (1999) 112-116
21. Rosenwald A., Ott G., Katzenberger T., Siebert R., Kalla J., Kuse R., Ott M.M., Müller-Hermelink H.K., and Schlegelberger B. Jumping translocation of 1q as the sole aberration in a case of follicular lymphoma. Cancer Genet Cytogenet 108 (1999) 53-56
22. Sawyer J.R., Tricot G., Mattox S., Jagannath S., and Barlogie B. Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood 91 (1998) 1732-1741
23. Sawyer J.R., Tricot G., Lukacs J.L., Binz R.L., Tian E., Barlogie B., and Shaughnessy Jr. J. Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q. Genes Chromosomes Cancer 42 (2005) 95-106
24. Park T.S., Lee S.T., Song J., Lee K.A., Kim J., Kim S.J., Lee J.H., Song S., and Choi J.R. A tandem triplication, trp(1)(q21q32), in a patient with follicular lymphoma: a case study and review of the literature. Cancer Genet Cytogenet 189 (2009) 127-131
25. ISCN 2009: an international system for human cytogenetic nomenclature (2005). Shaffer LG, Slovak ML, Campbell LJ. Basel: S. Karger, 2009.
26. Kong X.T., Ida K., Ichikawa H., Shimizu K., Ohki M., Maseki N., Kaneko Y., Sako M., Kobayashi Y., Tojou A., Miura I., Kakuda H., Funabiki T., Horibe K., Hamaguchi H., Akiyama Y., Bessho F., Yanagisawa M., and Hayashi Y. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 90 (1997) 1192-1199
27. Ladanyi M. The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 4 (1995) 162-173
28. Perrotti D., Bonatti S., Trotta R., Martinez R., Skorski T., Salomoni P., Grassilli E., Lozzo R.V., Cooper D.R., and Calabretta B. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J 17 (1998) 4442-4455
29. Ron D. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation. Curr Top Microbiol Immunol 220 (1997) 131-142
30. Panagopoulos I., Mandahl N., Mitelman F., and Aman P. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21). Oncogene 11 (1995) 1133-1137
31. Najfeld V., Hauschildt B., Scalise A., Gattani A., Patel R., Ambinder E.P., and Silverman L.R. Jumping translocations in leukemia. Leukemia 9 (1995) 634-639
32. Manola K.N., Georgakakos V.N., Stavropoulou C., Spyridonidis A., Angelopoulou M.K., Vlachadami I., Katsigiannis A., Roussou P., Pantelias G.E., and Sambani C. Jumping translocations in hematological malignancies: a cytogenetic study of five cases. Cancer Genet Cytogenet 187 (2008) 85-94
33. Okita H., Umezawa A., Fukuma M., Ando T., Urano F., Sano M., Nakata Y., Mori T., and Hata J. Acute myeloid leukemia possessing jumping translocation is related to highly elevated levels of EAT/mcl-1, a Bcl-2 related gene with anti-apoptotic functions. Leuk Res 24 (2000) 73-77
34. Minamihisamatsu M., and Ishihara T. Translocation (8;21) and its variants in acute nonlymphocytic leukemia: the relative importance of chromosomes 8 and 21 to the genesis of the disease. Cancer Genet Cytogenet 33 (1988) 161-173
35. Sadamori N., Yao E., Tagawa M., Nakamura H., Sasagawa I., Itoyama T., Tokunaga S., Ichimaru M., Nakamura I., Kamei T., and Yokoyama Y. 16;21 translocation in acute nonlymphocytic leukemia with abnormal eosinophils: a unique subtype. Acta Haematol 84 (1990) 212-216
36. Morgan R., Riske C.B., Meloni A., Ries C.A., Johnson C.H., Lemons R.S., and Sandberg A.A. t(16;21)(p11.2;q22): a recurrent primary rearrangement in ANLL. Cancer Genet Cytogenet 53 (1991) 83-90
37. Satoh K., Miura I., Chubachi A., Ohtani H., Hirokawa M., Niitsu H., and Miura A.B. Acute monoblastic leukemia (M5a) with dysmegakaryocytopoiesis associated with t(16;21) (p11;q22). [In Japanese]. Rinsho Ketsueki 35 (1994) 160-164
38. - myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 84 (1994) 244-255
39. Hiyoshi M., Yamane T., Hirai M., Tagawa S., Hattori H., Nakao Y., Yasui Y., Koh K.R., Hino M., and Tatsumi N. Establishment and characterization of IRTA17 and IRTA21, two novel acute non-lymphocytic leukaemia cell lines with t(16;21) translocation. Br J Haematol 90 (1995) 417-424
40. Hiyoshi M., Koh K.R., Yamane T., and Tatsumi N. Acute non-lymphoblastic leukaemia with t(16;21): case report with a review of the literature. Clin Lab Haematol 17 (1995) 243-246
41. Harigae H., Kobayashi M., Mihara A., and Watanabe N. Detection of minimal residual disease in cerebro-spinal fluid of a patient with acute myelogenous leukemia with t(16;21)(p11;q22) translocation by reverse transcriptase-polymerase chain reaction. Tohoku J Exp Med 183 (1997) 297-302
42. Tamura S., Takemoto Y., Hashimoto-Tamaoki T., Mimura K., Sugahara Y., Senoh J., Furuyama J.I., and Kakishita E. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia. Int J Oncol 12 (1998) 1259-1262
43. Imashuku S., Hibi S., Sako M., Lin Y.W., Ikuta K., Nakata Y., Mori T., Iizuka S., Horibe K., and Tsunematsu Y. Hemophagocytosis by leukemic blasts in 7 acute myeloid leukemia cases with t(16;21)(p11;q22): common morphologic characteristics for this type of leukemia. Cancer 88 (2000) 1970-1975
44. Okoshi Y., Shimizu S., Kojima H., Obara N., Mukai H.Y., Komeno T., Hasegawa Y., Mori N., and Nagasawa T. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation. Acta Haematol 105 (2001) 45-48
45. Fukushima Y., Fujii N., Tabata Y., Nishimura Y., Fusaoka T., Yoshihara T., Tsunamoto K., Kasubuchi Y., Morimoto A., Hibi S., Taketani K., Hayashi Y., and Imashuku S. AML(M7) associated with t(16;21)(p11;q22) showing relapse after unrelated bone marrow transplantation and disappearance of TLS/FUS-ERG mRNA. [In Japanese]. Rinsho Ketsueki 42 (2001) 502-506
46. Heller A., Loncarevic I.F., Glaser M., Gebhart E., Trautmann U., Claussen U., and Liehr T. Breakpoint differentiation in chromosomal aberrations of hematological malignancies: identification of 33 previously unrecorded breakpoints. Int J Oncol 24 (2004) 127-136
47. Choi H.W., Shin M.G., Sawyer J.R., Cho D., Kee S.J., Baek H.J., Kook H., Kim H.J., Shin J.H., Suh S.P., Hwang T.J., and Ryang D.W. Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukemia with 47, XX, + 10,t(16;21)(p11;q22). Cancer Genet Cytogenet 167 (2006) 172-176